“These projects represent a substantial investment in Gemini’s future, and being recognized with this award is a testament to the planning, collaboration and commitment from everyone across the organization and Suffolk County leaders,” said Michael Finamore, CEO of Gemini Pharmaceuticals.
“The improvements will have a substantial impact on our company through expanded capabilities, allowing us to better serve our customers by consistently delivering cutting-edge items and increasing our production capacity. They will also impact our community through new job creation.”
The “2025 Project of the Year” will add 50 jobs over the next 18 to 24 months, Finamore told NutraIngredients.
“We have taken over a bigger footprint on Long Island, more space,” he said. “We are spending a good deal of money and expanding our ideation and our laboratory services.
“One of the things that makes Gemini different is the ability for our customers and our partners to come to Gemini and work hand-in-hand with our development team in a GMP part, separate from the rest of the facility, understanding about the ingredients and things we do. So being able to do that and an analytical component to that we know is something that been very, very popular, and especially this age where people, whether the influencers or others, really want to get hands on.”
In addition to the expanded R&D space, the company will also be improving the overall external appearance of the campus, upgrading several packaging lines to significantly increase throughput, creating a new area that will broaden Gemini’s technical capabilities to support emerging product categories, including probiotics, and undertaking complex infrastructure improvements to ensure ongoing environmental compliance.
“We’re a family-owned company, privately held,” Finamore said. “Knowing that this is where we’re going to be for a while, we’re comfortable making those investments.”
Kelly Murphy, CEO of the Suffolk County Industrial Development Agency, said the agency was proud to recognize Gemini with its 2025 Project of the Year award.
“Gemini Pharmaceuticals’ commitment to expanding its operations here in Suffolk County is exactly the kind of investment that strengthens our regional economy,” Murphy said. “This project supports innovation within a critical and growing industry and creates high-quality jobs and reinforces Long Island’s position as a hub for advanced manufacturing.”
Confidence in the future
According to a press release from the company, Gemini is undertaking these actions to keep pace with the rapidly growing global dietary supplement market.
Despite a number of challenges over the past 12 months, from an election cycle and tariffs upending the industry to GLP-1 disrupting the weight management category, Finamore and his team are optimistic about the industry’s trajectory.
“I know for Gemini and some of my friends in the space, the first quarter was very, very interesting,” he said. “But now, looking at where industry is going, and where I see our partners investing in certain things, in certain products, in certain ingredients, I think we’re going to take up where this industry left off prior to last fall.
“The ideation pipeline for [our partners] is strong and so we’re very happy that that’s good tidings for us, that means they’re investing in this industry as well. So for us, we feel very strong about the future.”
